NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk
Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
Wegovy pill could deliver as much weight loss as the shot, trial shows
Eli Lilly and Novo Nordisk are vying for supremacy in the weight-loss market they dominate as they both…